Accepted at 1:42 p.m. Jan, 26, 2024 by Cameron
Author: Jwill
Co-authors: Cameron
Related Note: 1543504724150
Rationale for change

Metformin induces weight loss (per FA23 pg359, AMBOSS, and nid:1462913267342)
- or stabilization per AMBOSS

Reorder agents in extra for better flow and relevance to the card weight loss->neutral-> gain
Source: AMBOSS - https://next.amboss.com/us/article/7m04Sg?utm_source=navbar&utm_medium=anki&utm_campaign=anki&utm_term=metformin&guid=dXa0I%2FU%257CiJ&aid=3dcc458e-7f56-4577-a733-e7de1b7743d9&uid=ij5gJZ4Da#Zfbd744168d541d2a68c84d499f310cb7

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#AMBOSS::02aeTP #AK_Step2_v12::#Resources_by_rotation::IM::uw::endocrine_diabetes_metabolism::endocrine_diabetes_metabolism_dorian #AK_Step1_v12::#B&B::09_Endocrinology::03_Pancreas::06_Treatment_of_Diabetes_Mellitus #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::02_Metformin,_Thiazolidinediones,_Pramlintide,_SGLT2_Inhibitors #AK_Step1_v12::#Pixorize::03_Pharmacology::08_Diabetes_Drugs_(Old)::07_GLP-1_Analogs #AK_Step2_v12::Original_decks::Dorian::im::ome::endo::outpatient_dm #AK_Step3_v12::#UWorld::107729 #AK_Step2_v12::#AMBOSS::OBaIaM #AK_Step2_v12::#UWorld::Step::16507 #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Endocrinology::Outpatient_Type_2_Diabetes_Mellitus #AK_Step2_v12::#Resources_by_rotation::IM::ome::endo::outpatient_dm #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::05_Diabetes_Treatment::Extra #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::06_Retired_Lessons::03_Metformin,_thiazolidinediones,_pramlintide,_SGLT2_inhibitors_[Retired_Video] #AK_Step2_v12::#UWorld::COMLEX::103504 #AK_Step2_v12::Original_decks::Dorian::im::uw::endocrine #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::02_GLP-1_Analogs #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::09_SGLT2_Inhibitors #AK_Step2_v12::#Resources_by_rotation::FM::ome::endo::outpatient_dm #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Endocrine,_Diabetes,_&_Metabolism #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::01_Insulin,_sulfonylureas,_meglitinides,_GLP-1_agonists,_DPP-4_inhibitors #AK_Step2_v12::#UWorld::#UWSA1 #AK_Step2_v12::#Subjects::Endocrinology::06_Pancreas::Diabetes::*Management_REDO #AK_Step3_v12::#UWorld::5061 #AK_Step2_v12::Original_decks::Dorian::fam::ome::endo::outpatient_dm #AK_Step2_v12::#AMBOSS::8E0Ox3 #AK_Step2_v12::!Shelf::FM #AK_Step2_v12::#UWorld::Step::6921 #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step2_v12::#UWorld::COMLEX::28010 #AK_Step1_v12::#AMBOSS #AK_Step2_v12::#FirstAid::03_Endocrinology::01_Disorders_of_Glucose_Metabolism::02_Diabetes_Mellitus #PANCE::ENDO::diabetes #AK_Step2_v12::#Resources_by_rotation::IM::uw::endocrine_diabetes_metabolism::endocrine_diabetes_metabolism_zanki #AK_Step2_v12::#UWorld::Step::2192 #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::!Shelf::IM #AK_Step2_v12::#OME::01_Medicine::07_Endocrinology::06_Outpatient_Type_2_Diabetes #PANCE::EOR::IM